Strata Skin Sciences Market Cap 2010-2025 | SSKN
Strata Skin Sciences market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Strata Skin Sciences market cap as of June 25, 2025 is $0.01B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.674B | 58.11 |
| Tempus AI (TEM) | United States | $11.334B | 0.00 |
| Doximity (DOCS) | United States | $11.302B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $9.269B | 96.30 |
| IRhythm Technologies (IRTC) | United States | $4.836B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.893B | 60.83 |
| Hinge Health (HNGE) | United States | $3.474B | 0.00 |
| Privia Health (PRVA) | United States | $2.652B | 181.25 |
| Enovis (ENOV) | United States | $1.835B | 10.23 |
| Phreesia (PHR) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.509B | 0.00 |
| 10x Genomics (TXG) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.397B | 64.92 |
| Clover Health Investments (CLOV) | United States | $1.394B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.75 |
| Evolent Health (EVH) | United States | $1.257B | 107.10 |
| Claritev (CTEV) | United States | $0.687B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Talkspace (TALK) | United States | $0.452B | 135.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.343B | 762.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.048B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |